What You Need to Know about Proposed DEA Rules on Prescribing Controlled Substances via Telehealth
On February 23rd, the Drug Enforcement Administration (DEA) issued proposed rules on post-COVID-19 public health emergency (PHE) flexibilities surrounding the prescribing of controlled substances via telehealth. The proposed rules extend many of the flexibilities adopted during the public health emergency with appropriate safeguards.
Join Emily Diehl, Manager, Federal Policy & Advocacy, as she reviews the proposed rules and helps you stay informed about what you need to know.
Participants of this webinar will:
- Learn about the DEA regulations before and during the COVID-19 public health emergency.
- Understand the proposed rules from the DEA and the impact on care delivery.
- Be prepared to propose comments, if interested.